| scholarly article | Q13442814 |
| P2093 | author name string | Apurva R Patel | |
| Chandraiah Godugu | |||
| Mandip Singh | |||
| Ravi Doddapaneni | |||
| Srujan Marepally | |||
| Tanise Jackson | |||
| P2860 | cites work | Inhalation Delivery of a Novel Diindolylmethane Derivative for the Treatment of Lung Cancer | Q34300257 |
| Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo | Q34503877 | ||
| Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors | Q34582878 | ||
| Delivering nanomedicine to solid tumors | Q34726981 | ||
| Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. | Q35641963 | ||
| Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration | Q35677437 | ||
| Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor | Q35857448 | ||
| Angiotensin peptides and lung cancer | Q35857462 | ||
| Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats | Q35884929 | ||
| Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis | Q36075240 | ||
| TGF beta signalling and its role in tumour pathogenesis | Q36180627 | ||
| TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. | Q36339786 | ||
| A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer Biology | Q36743890 | ||
| Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations | Q36921222 | ||
| Emerging trends of nanomedicine--an overview | Q37519820 | ||
| The renin-angiotensin system and cancer: old dog, new tricks. | Q37802186 | ||
| Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy. | Q37847515 | ||
| The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis | Q37964588 | ||
| Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression | Q37970379 | ||
| Management of small cell lung cancer: recent developments for optimal care | Q37987205 | ||
| EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells | Q38498023 | ||
| Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells | Q39285206 | ||
| Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis | Q39340215 | ||
| Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1. | Q39340234 | ||
| Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring | Q39713271 | ||
| The effect of Telmisartan on collagen biosynthesis depends on the status of estrogen activation in breast cancer cells. | Q39769660 | ||
| Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action | Q40144286 | ||
| Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. | Q40158311 | ||
| Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer | Q40219744 | ||
| Irradiation reduces interstitial fluid transport and increases the collagen content in tumors | Q40610853 | ||
| Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts | Q41887621 | ||
| Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers | Q42512492 | ||
| Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action. | Q42747102 | ||
| Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector | Q45419303 | ||
| Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size | Q47348224 | ||
| Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors. | Q54650279 | ||
| TGF beta-1 regulation of VEGF production by breast cancer cells | Q73992257 | ||
| Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma | Q83611006 | ||
| AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist | Q24652842 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Therapeutic nanoparticles for drug delivery in cancer | Q28271255 | ||
| Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Q28278682 | ||
| Increase in tumour permeability following TGF-beta type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI | Q28749643 | ||
| Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition | Q30498249 | ||
| Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer | Q30499935 | ||
| Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice | Q33534042 | ||
| Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials | Q33803829 | ||
| Telmisartan as a peroxisome proliferator-activated receptor-γ ligand is a new target in the treatment of human renal cell carcinoma | Q33865772 | ||
| Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity | Q33976477 | ||
| Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation | Q34163525 | ||
| Angiotensin II facilitates breast cancer cell migration and metastasis | Q34247434 | ||
| Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells | Q34280097 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| nanoparticle | Q61231 | ||
| P304 | page(s) | 86-95 | |
| P577 | publication date | 2013-07-07 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models | |
| P478 | volume | 172 |
| Q91656875 | Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway |
| Q55073347 | An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines. |
| Q35116352 | Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. |
| Q38753809 | Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells. |
| Q89657824 | Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments |
| Q38778869 | Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer |
| Q90581683 | Engineering Tumor-Targeting Nanoparticles as Vehicles for Precision Nanomedicine |
| Q38714359 | Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). |
| Q37587394 | Inhalable oridonin-loaded poly(lactic-co-glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer |
| Q37565209 | NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil |
| Q26774177 | Nanotechnology-based inhalation treatments for lung cancer: state of the art |
| Q61443239 | Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation |
| Q37426564 | Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer |
| Q36641553 | Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma |
| Q38748639 | Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer. |
| Q59808955 | Peritumoral implantation of hydrogel-containing nanoparticles and losartan for enhanced nanoparticle penetration and antitumor effect |
| Q92941714 | Preparation, Optimization, and In Vivo Evaluation of Nanoparticle-Based Formulation for Pulmonary Delivery of Anticancer Drug |
| Q39306543 | Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities |
| Q47311101 | Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer |
| Q90380059 | Sustained-Release Curcumin Microparticles for Effective Prophylactic Treatment of Exocrine Dysfunction of Pancreas: A Preclinical Study on Cerulein-Induced Acute Pancreatitis |
| Q92098341 | Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells |
| Q47863448 | Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. |
| Q52649660 | Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway. |
| Q97525015 | The therapeutic potential of losartan in lung metastasis of colorectal cancer |
| Q37013337 | Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer |
Search more.